NeuroBo Pharmaceuticals (NRBO) Stock Chart & Stock Price History $0.61 -0.03 (-4.65%) As of 07/30/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NeuroBo Pharmaceuticals Stock Price Performance The NeuroBo Pharmaceuticals (NRBO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 83.99%, with a year-to-date return of -69.44%. In the past month, the stock has decreased 5.92%, reflecting recent market activity. As of the latest close, NeuroBo Pharmaceuticals traded at $0.61 with a market cap of $5.21 million and volume of 60,900 shares. Five years ago, the stock traded at a split-adjusted price of $1,538.40, representing a 99.96% decrease over that period. At the time, it had a market cap of $105.48 million and a volume of 4,980 shares. Receive NRBO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-17.86%1 Month Performance-5.92%3 Month Performance-20.49%Year-To-Date Performance-69.44%1 Year Performance-83.99%5 Year Performance-99.96% NRBO Stock Chart for Friday, August, 1, 2025 NRBO Chart by TradingView NeuroBo Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/31/2025$0.66$0.61-8.79%$0.64$0.6060,900 shs$5.21 million07/30/2025$0.66$0.66$0.71$0.6680,953 shs$5.72 million07/29/2025$0.71$0.66-5.90%$0.71$0.6680,953 shs$5.72 million07/28/2025$0.71$0.71$0.73$0.6858,579 shs$6.08 million07/25/2025$0.70$0.74+5.24%$0.75$0.7188,564 shs$6.35 million07/24/2025$0.70$0.70$0.70$0.6724,525 shs$6.03 million07/23/2025$0.68$0.70+2.93%$0.70$0.6724,525 shs$6.03 million07/22/2025$0.67$0.68+0.92%$0.70$0.6755,907 shs$5.86 million07/21/2025$0.67$0.67$0.69$0.6741,396 shs$5.81 million07/18/2025$0.67$0.67-0.40%$0.71$0.6753,211 shs$5.78 million Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/17/2025$0.67$0.67+0.93%$0.69$0.6714,409 shs$5.81 million07/16/2025$0.71$0.67-5.97%$0.71$0.6644,812 shs$5.75 million07/15/2025$0.72$0.71-1.13%$0.72$0.6982,490 shs$6.12 million07/14/2025$0.72$0.72$0.72$0.7049,045 shs$6.19 million07/11/2025$0.69$0.69$0.70$0.63115,357 shs$5.95 million07/10/2025$0.64$0.69+8.21%$0.70$0.63115,357 shs$5.95 million07/09/2025$0.62$0.64+2.65%$0.64$0.6279,747 shs$5.50 million07/08/2025$0.65$0.62-3.98%$0.65$0.6058,024 shs$5.36 million07/07/2025$0.65$0.65$0.67$0.6348,968 shs$5.58 million07/04/2025$0.66$0.65-2.10%$0.67$0.6348,968 shs$5.58 million07/03/2025$0.65$0.66+1.82%$0.67$0.6559,409 shs$5.70 million07/02/2025$0.64$0.65+1.06%$0.68$0.6440,632 shs$5.60 million07/01/2025$0.63$0.64+2.10%$0.65$0.6376,753 shs$5.54 million06/30/2025$0.63$0.63$0.70$0.63176,619 shs$5.43 million Related Companies WVS Financial Stock Price Chart 9F Stock Price Chart SAIHEAT Stock Price Chart Sphere 3D Stock Price Chart Glen Burnie Bancorp Stock Price Chart Carver Bancorp Stock Price Chart Netcapital Stock Price Chart Mawson Infrastructure Group Stock Price Chart Mill City Ventures III Stock Price Chart SHF Stock Price Chart Receive NRBO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRBO) was last updated on 8/1/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredWhy “The Prophet” Is Betting Big on This $10 StockAmerica's Biggest Land Grab Is Not Where You Think While the media focuses on coastal cities and farmland.....Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto America27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.